← Open Payments lookup

CASEY ENGLISH: Open Payments

NPI 1780259135 · LONGVIEW, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,946 in 150 payments from 17 companies in 2025. Trend: 2023 $963 · 2024 $2,005 · 2025 $2,946

Food & beverage: $2,493Education: $453
CompanyPaymentsAmount
ABBVIE INC.30$410
GENZYME CORPORATION16$367
Regeneron Healthcare Solutions, Inc.9$351
SUN PHARMACEUTICAL INDUSTRIES INC.10$332
Janssen Biotech, Inc.16$313
UCB, Inc.13$269
Galderma Laboratories, L.P.14$203
E.R. Squibb & Sons, L.L.C.17$182
Novartis Pharmaceuticals Corporation8$137
SANOFI-AVENTIS U.S. LLC1$99

Products named: DUPIXENT, TREMFYA, Bimzelx, RINVOQ, NEMLUVIO, SKYRIZI, Sotyktu, ILUMYA.

Industry payments across TX — which companies pay providers there.